Fundz

Genomenon, Inc. reported raising $20 Million in an initial SEC Form D filing, from an offering of $20 Million

PRIVATEMar 10, 2022

Amount Raised

$20 Million

$20 Million sold, per SEC Form D (first sale Mar 10, 2022)

Round Type

Venture

Ann ArborBiotechnologyHardwareresearch

Quick answer

Genomenon, Inc. raised $20 Million in a funding round, dated March 10, 2022. Genomenon, Inc. is based in Ann Arbor, Michigan, United States.

How much did Genomenon, Inc. raise?
Genomenon, Inc. raised $20 Million in a funding round on March 10, 2022.
What does Genomenon, Inc. do?
Genomenon is a genomics intelligence company dedicated to improving the quality of life of genetic disease and cancer patients by making genomic information actionable.
Where is Genomenon, Inc. based and how big is it?
Genomenon, Inc. is based in Ann Arbor, Michigan, United States. Fundz records about 140 employees.
Who are the decision-makers at Genomenon, Inc?
Fundz holds 4 contacts at Genomenon, Inc., including the Chief Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Genomenon, Inc., and when

A new round usually means Genomenon, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Genomenon, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Genomenon, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Genomenon, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Genomenon, Inc.

Location

3135 S. STATE STREET

Ann Arbor, Michigan, United States

About

Genomenon is a genomics intelligence company dedicated to improving the quality of life of genetic disease and cancer patients by making genomic information actionable. Blending the power of AI with the precision of genomic expertise, the company empowers pharmaceutical companies and the clinical diagnostic community with empirical genomic evidence and insights that both support the development of novel therapeutics and speed diagnostic assessments and treatment recommendations.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Genomenon, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contactsMike K., Chief Executive Officer hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Genomenon, Inc.'s next move

See what Strategic adds

Genomenon, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.